NEWS
Dr. David T. Rubin Reflects on How to Avoid the Next Pandemic with WGN’s Steve Dale
Click here to listen to the full interview.
Dr. David T. Rubin Summarizes His Presentation from the Advances in Inflammatory Bowel Diseases Conference on Preparing for IBD Care in the Next Pandemic
Click here for the full video of Dr. Rubin detailing his 8-point strategy for steps the gastroenterology community should take to prepare for another pandemic in the future to ensure the best outcomes for patients and conditions for professionals.
Newly Discovered Vascular Barrier in the Brain May Explain IBD-Related Anxiety, Depression
A newly discovered vascular brain barrier that blocks the passage of inflammatory molecules triggered by gut bacteria may be why patients with inflammatory bowel disease (IBD) are at increased risk for certain mental health disorders, including anxiety and depression, early research suggests.
Click here to read the full article, and here to read the publication “Identification of a choroid plexus vascular barrier closing during intestinal inflammation” in Science.
Dr. David T. Rubin Reviews His Presentation from the American College of Gastroenterology Scientific Meeting on Therapeutic Drug Monitoring in IBD
Click here for the full video of Dr. Rubin reviewing his presentation from the American College of Gastroenterology Scientific Meeting on therapeutic drug monitoring (TDM), including the appropriate application of proactive TDM in the treatment of inflammatory bowel disease.
Rectal Compliance Lower Than Normal in Ulcerative Colitis, but Recovery Is Possible
“The findings did not surprise us, but supported our hypothesis that patients with UC have reduced compliance of their rectum, even when they are in remission,” Dr. Rubin told Reuters Health by email. “The exciting new finding is that those who normalized their histology – i.e., biopsies show no evidence of chronic colitis – had compliance similar to the non-colitis control group.”
Click here to read the full article, and here to read the publication “Ulcerative colitis patients have reduced rectal compliance compared with non-IBD controls” in Gastroenterology.
IBD Drive Time: Dr. David Rubin, MD, on Ozanimod in Ulcerative Colitis
Click here to listen to Dr. Rubin speak with colleagues and IBD Drive Time hosts Raymond Cross, MD and Millie Long, MD on using newly-approved ozanimod in treating ulcerative colitis.
What Can We Do To Prevent COVID-19?
Click here for the full video discussing the use of COVID-19 vaccines to prevent COVID-19 infections in patients with inflammatory bowel disease.
Dr. David T. Rubin and His Colleagues Discuss COVID-19 Vaccines for Patients with IBD
Click here for the full video of Drs. Rubin, Siegel, Melmed, and Horrigan discussing the safety and efficacy of COVID-19 vaccines for patients with inflammatory bowel disease.
Dr. Rubin Discusses Advances in Anti-Cytokine Therapy: The Current and Potential Role of IL-12/23 and IL-23 Inhibitors in the Treatment of IBD
Click here to watch Dr. Rubin discuss the advances in anti-cytokine therapy and receive AANP, AAPA, CME, CNE, CPE, or participation credit.
VIDEO: Social media has been a ‘life saver’ during COVID-19 pandemic
Watch this video exclusive, to hear David T. Rubin, MD highlight how the COVID-19 pandemic changed the use of social media.